Sylvie Gregoire has bought stock on 3 days since Nov 2025

Sylvie Grégoire is a pharmaceutical and biotechnology executive and corporate board member with more than 30 years of industry experience. She is the founder of CervoMed and has served on its board since 2018, including as Non-Executive Chair from August 2023 to February 2024 and as a director thereafter; CervoMed also identifies her as a co-founder of the company (formerly EIP Pharma). She currently serves as Chairman of Abivax SA and has also held board roles at Novo Nordisk, Revvity (formerly PerkinElmer), and other health sciences companies. (

Earlier in her career, Dr. Grégoire held senior leadership roles at Shire (including President of the Rare Disease division), GlycoFi as CEO, and in executive positions at Biogen and Merck & Co. across North America and Europe. Her education includes a doctorate from the State University of New York at Buffalo and undergraduate degrees from Université Laval and Séminaire de Sherbrooke. Recent SEC-related reporting identifies her as a CervoMed director and 10% owner, reflecting her substantial equity position in the company. (

Written by Perplexity from public sources.